BREAST ANGIOSARCOMA METASTATIC

This adverse event was reported 8 times

BREAST ANGIOSARCOMA METASTATIC is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 REPOTRECTINIB 1 0.0036
1 EPIRUBICIN HYDROCHLORIDE 1 0.0002
2 CRIZOTINIB 1 0.0001
3 PAZOPANIB HYDROCHLORIDE 2 0.0001
4 THALIDOMIDE 2 0.0001
5 GEMCITABINE HYDROCHLORIDE 2 0.0000
6 DOXORUBICIN 3 0.0000
7 DOCETAXEL 2 0.0000
8 DOCETAXEL ANHYDROUS 2 0.0000
9 PROPRANOLOL HYDROCHLORIDE 2 0.0000
See all drugs enriched for association with BREAST ANGIOSARCOMA METASTATIC

BREAST ANGIOSARCOMA METASTATIC is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Topoisomerase Inhibitor [EPC] 2 0.0000
1 Microtubule Inhibitor [EPC] 4 0.0000
2 Programmed Death Receptor-1 Blocking Antibody [EPC] 1 0.0000
3 Alkylating Drug [EPC] 2 0.0000
4 RANK Ligand Inhibitor [EPC] 1 0.0000
5 Kinase Inhibitor [EPC] 1 0.0000
6 Nonsteroidal Anti-inflammatory Drug [EPC] 2 0.0000
See all drug classes enriched for association with BREAST ANGIOSARCOMA METASTATIC